Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-013398)

Filing Details

Accession Number:: 0001209191-23-013398
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-02-27 19:14:01
Reporting Period:: 2023-02-23

Accepted Time:: 2023-02-27 19:14:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1802768	Royalty Pharma Plc	RPRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1814899	W. George Lloyd	C/O Royalty Pharma Plc 110 East 59Th Street New York NY 10022	Evp, Investments & Clo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Disposition	2023-02-23	25,000	$37.27	325,000	No	4	S	Indirect	By GWL 2014 G, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By GWL 2014 G, LLC

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Class A Ordinary Shares	495,860	Indirect	By GWL 2013 NG, LLC
Class A Ordinary Shares	273,960	Indirect	By IRA
Class A Ordinary Shares	130,000	Indirect	By GWL 2020 G, LLC
Class A Ordinary Shares	3,000	Direct
Class A Ordinary Shares	4,011	Indirect	By Spouse

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.19 to $37.37 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.